Europe — EMA
Paliperidon Teva (Paliperidone Palmitate)
Paliperidone palmitate, the active ingredient in Paliperidon Teva, is a long‑acting antipsychotic presented as a sterile powder for intramuscular injection use.
Request sourcing
What is Paliperidone Palmitate?
Paliperidone palmitate, the active ingredient in Paliperidon Teva, is a long‑acting antipsychotic presented as a sterile powder for intramuscular injection use. It is indicated for the treatment of schizophrenia in adult patients. GNH USA supplies Paliperidon Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Paliperidon Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Paliperidone Palmitate used for?
Paliperidone palmitate is used in the management of schizophrenia, a chronic psychotic disorder that affects thought processes and perception.
- Schizophrenia: Reduces risk of relapse and stabilises symptoms when administered as a monthly injection. - Schizoaffective disorder: Provides sustained symptom control over several weeks. - Maintenance therapy after acute stabilization: Helps maintain clinical stability without daily oral dosing.
What are the side effects of Paliperidone Palmitate?
Paliperidone palmitate may cause a range of adverse reactions, most of which are dose‑dependent and reversible.
Common Side Effects: - Injection site pain - Weight gain - Akathisia (inner‑movement discomfort - Drowsiness - Constipation - Fatigue
Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Tardive dyskinesia - Severe hypotension - Hyperglycaemia - Elevated ... - ... ...
What precautions apply to Paliperidone Palmitate?
Palicer... ... ... ... ... ... ... ... ... ... ... … … ... t .... ... ... ... ... ... ...
What does Paliperidone Palmitate interact with?
...
